Home » Stocks » QDEL

Quidel Corporation (QDEL)

Stock Price: $167.89 USD 3.63 (2.21%)
Updated Mar 1, 2021 2:47 PM EST - Market open
Market Cap 6.95B
Revenue (ttm) 1.66B
Net Income (ttm) 810.29M
Shares Out 42.12M
EPS (ttm) 18.60
PE Ratio 9.03
Forward PE 20.33
Dividend n/a
Dividend Yield n/a
Trading Day March 1
Last Price $167.89
Previous Close $164.26
Change ($) 3.63
Change (%) 2.21%
Day's Open 170.15
Day's Range 166.69 - 173.50
Day's Volume 563,236
52-Week Range 73.01 - 306.72

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GuruFocus - 5 days ago

Investors in search of opportunities amid growing companies could be interested in the following three stocks, as their share prices are trading lower than their Peter Lynch Fair Values.

Other stocks mentioned: HIG, TOL
The Motley Fool - 6 days ago

Investors are starting to get worried now that COVID-19 is possibly declining.

Business Wire - 6 days ago

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announ...

The Motley Fool - 1 week ago

It's possible that some stocks could fly higher with the policy change being considered by the Biden administration.

Other stocks mentioned: ABT, BDX, FLGT
The Motley Fool - 1 week ago

The company released its fourth-quarter and full-year 2020 earnings report.

The Motley Fool - 1 week ago

The diagnostics company delivered impressive top- and bottom-line growth. But it wasn't enough to fire up investors.

Zacks Investment Research - 1 week ago

Quidel (QDEL) delivered earnings and revenue surprises of 9.60% and -0.03%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 1 week ago

Shares of Quidel (NASDAQ:QDEL) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 1007.00% over the past year to $11.07, wh...

Business Wire - 1 week ago

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced toda...

Zacks Investment Research - 1 week ago

Quidel Corp (QDEL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 2 weeks ago

Quidel (QDEL) closed the most recent trading day at $236.38, moving +1.5% from the previous trading session.

Zacks Investment Research - 2 weeks ago

Quidel (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

GuruFocus - 2 weeks ago

Mario Gabelli (Trades, Portfolio), founder of GAMCO Investors, has revealed his portfolio for the fourth quarter. Major trades include reductions in his Rollins Inc. (NYSE:ROL), Navistar Inter...

Other stocks mentioned: GLIBA, HRI, LBRDK, NAV, ROL, SNE
Zacks Investment Research - 3 weeks ago

Quidel (QDEL) is likely to have witnessed a recovery in rapid immunoassay revenues during Q4.

Zacks Investment Research - 3 weeks ago

Quidel (QDEL) closed at $236.85 in the latest trading session, marking a +1.29% move from the prior day.

Business Wire - 3 weeks ago

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic syst...

Business Wire - 1 month ago

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will r...

Zacks Investment Research - 1 month ago

Quidel (QDEL) closed at $224.21 in the latest trading session, marking a -0.87% move from the prior day.

Zacks Investment Research - 1 month ago

Top Ranked Growth Stocks to Buy for January 25th

Other stocks mentioned: APAM, FOCS, MTH
Seeking Alpha - 1 month ago

Two new breakout stocks for Week 4 of 2021 with better than 10% short-term upside potential. This past week 3 out of 4 stocks gained over 10% in a short trading week but gave back most of thei...

Other stocks mentioned: AAPL, AMGN, DIS, DOW, HD, JNJ, MRK, NKE, NVR, TRV, VSTO
Investopedia - 1 month ago

These are the healthcare stocks with the best value, fastest growth, and most momentum for February 2021.

Other stocks mentioned: BIIB, BIO, CVS, HZNP, MRNA, PODD, TDOC
Zacks Investment Research - 1 month ago

The Department of Health and Human Services (HHS) promises over $22 billion of funding.

Other stocks mentioned: ABT, BDX, HOLX
GuruFocus - 1 month ago

For many companies, the Covid-19 pandemic has brought trouble and turmoil, with many wondering if they will survive. For other companies, though, it has been a bonanza.

Zacks Investment Research - 1 month ago

Investors who have the propensity to take a higher risk can think of investing in momentum stocks to boost their gains.

Other stocks mentioned: BIDU, CROX, HLF
Zacks Investment Research - 1 month ago

Quidel (QDEL) closed the most recent trading day at $198.03, moving +0.05% from the previous trading session.

Zacks Investment Research - 1 month ago

Quidel (QDEL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research - 1 month ago

QDEL vs. RMD: Which Stock Is the Better Value Option?

Other stocks mentioned: RMD
The Motley Fool - 1 month ago

The need for frequent and quick COVID-19 testing ensures that demand for its products won't slow down anytime soon.

Zacks Investment Research - 1 month ago

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

Other stocks mentioned: ABT, BDX, DGX, HOLX, LH, QGEN
Business Wire - 1 month ago

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ann...

Zacks Investment Research - 1 month ago

Top Ranked Momentum Stocks to Buy for January 7th

Other stocks mentioned: CLW, TTGT
Zacks Investment Research - 1 month ago

Top Ranked Momentum Stocks to Buy for January 5th

Other stocks mentioned: FOXF, PFSI, WGO
Zacks Investment Research - 1 month ago

Is (QDEL) Outperforming Other Medical Stocks This Year?

Zacks Investment Research - 1 month ago

Investors with a high-risk appetite might give the Driehaus strategy a thought to boost their returns.

Other stocks mentioned: FBK, PFSI, WGO
The Motley Fool - 1 month ago

Companies continue to develop new tests to detect COVID-19.

Other stocks mentioned: ABT
Zacks Investment Research - 1 month ago

Shopify (SHOP), Trade Desk (TTD), Williams-Sonoma (WSM) and Quidel (QDEL) are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.

Other stocks mentioned: SHOP, TTD, WSM
Zacks Investment Research - 2 months ago

Quidel (QDEL) closed at $197.49 in the latest trading session, marking a -1.26% move from the prior day.

Business Wire - 2 months ago

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic syst...

Zacks Investment Research - 2 months ago

We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.

Other stocks mentioned: CDNA, FLGT, OMI
Seeking Alpha - 2 months ago

Three referenced quant rating categories (value, growth, and profitability) are significant considerations in selecting healthcare investments. The data underlying the value, growth, and profi...

Other stocks mentioned: CODX, CPRX
Investopedia - 2 months ago

These are the healthcare stocks with the best value, fastest growth, and most momentum for January 2021.

Other stocks mentioned: BIIB, BIO, CVS, HZNP, MRNA, PODD, XLRN, XLV
The Motley Fool - 2 months ago

One of the company's COVID-19 tests received emergency use authorization.

The Motley Fool - 2 months ago

A new point-of-care test is both fast and accurate.

Zacks Investment Research - 2 months ago

Based on strong fundamentals, here we talk about four healthcare stocks to keep in your watchlist for 2021.

Other stocks mentioned: AZN, LHCG, RGEN
Business Wire - 2 months ago

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic syst...

Zacks Investment Research - 2 months ago

The U.S. healthcare sector emerged as one of the very few sectors that has been able to turn the misfortunes of COVID-19 pandemic to its advantage. The ongoing COVID-19 outbreak and an aging U...

Other stocks mentioned: BCRX, HALO, TDOC, XLRN
Zacks Investment Research - 2 months ago

In the latest trading session, Quidel (QDEL) closed at $196.43, marking a +1.7% move from the previous day.

Zacks Investment Research - 2 months ago

With Vaccine Distribution, What Stocks Do I Buy?

Other stocks mentioned: GS, SCHW
Zacks Investment Research - 2 months ago

Bull of the Day: Quidel (QDEL)

Business Wire - 2 months ago

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ann...

About QDEL

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing ... [Read more...]

Industry
Diagnostics & Research
Founded
1979
CEO
Douglas Bryant
Employees
1,370
Stock Exchange
NASDAQ
Ticker Symbol
QDEL
Full Company Profile

Financial Performance

In 2020, QDEL's revenue was $1.66 billion, an increase of 210.66% compared to the previous year's $534.89 million. Earnings were $810.29 million, an increase of 1,011.18%.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for QDEL stock is "Buy." The 12-month stock price forecast is 280.25, which is an increase of 66.93% from the latest price.

Price Target
$280.25
(66.93% upside)
Analyst Consensus: Buy